| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1987;43:144-149
© 1987 The Society of Thoracic Surgeons
From the Section of Thoracic and Cardiovascular Surgery, Department of Surgery, Wayne State University School of Medicine, Detroit, MI
* Address reprint requests to Dr. Arbulu, 4160 John R St, Suite 829, Detroit, MI 48201
Infective endocarditis remains a serious illness with a high mortality. In more than 75% of 417 patients, the infection was due to gram-positive microorganisms. The non-drug-addicted patients (33%) were elderly and debilitated with advanced illness that preceded the endocarditis. The drug-addicted patients (67%) were young and were infected with multiple kinds of microorganisms. The blood cultures grew strains of Staphylococcus aureus resistant to methicillin sodium and nafcillin sodium in a majority of patients. Gram-negative microorganisms and fungi were cultured almost exclusively from samples from the drug-addicted patients. The high mortality among the non-drug-addicted patients (28%) was related to their advanced age and debilitating illness. The high mortality among the drug-addicted patients (21%) was related to the complex bacteriology of their infections and the severe anatomical disruption of the valvular complexes of the heart. When cured of their disease after treatment with intravenously administered antibiotics or a valve procedure or both, their long-term survival was related to whether or not they abstained from their habit. If the patient abstained from the use of drugs, the chances of survival were good; if not, death invariably ensued. This experience strongly supports our contention that if a patient returns to the use of drugs and reinfects the valve after initial cure, a second valve operation is contraindicated.
This article has been cited by other articles:
|
|
 |
|
  A. Wahba and D. Nordhaug What are the long-term results of cardiac valve replacements in left sided endocarditis with a history of i.v. drug abuse? Interact CardioVasc Thorac Surg, October 1, 2006; 5(5): 608 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lee and M. R. Moon Homograft valve repair for recurrent prosthetic valve endocarditis J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 725 - 727. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bishara, L. Leibovici, D. G. Israel, A. Sagie, A. Kazakov, E. Miroshnik, S. Ashkenazi, and S. Pitlik Long-Term Outcome of Infective Endocarditis: The Impact of Early Surgical Intervention Clinical Infectious Diseases, November 15, 2001; 33(10): 1636 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bauernschmitt, H. G. Jakob, C.-F. Vahl, R. Lange, and S. Hagl Operation for Infective Endocarditis: Results After Implantation of Mechanical Valves Ann. Thorac. Surg., February 1, 1998; 65(2): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mathew, T. Addai, A. Anand, A. Morrobel, P. Maheshwari, and S. Freels Clinical Features, Site of Involvement, Bacteriologic Findings, and Outcome of Infective Endocarditis in Intravenous Drug Users Arch Intern Med, August 7, 1995; 155(15): 1641 - 1648. [Abstract] [PDF]
|
|
|
|
|
|
G. Watanabe, A. Haverich, R. Speier, C. Dresler, and H. G. Borst Surgical treatment of active infective endocarditis with paravalvular involvement J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 171 - 177. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Stoneburner Jr, B. L. Tucker, and R. J. Hurvitz Survival after embolization of a complete prosthetic aortic valve to the aortic arch Ann. Thorac. Surg., January 1, 1990; 49(1): 140 - 142. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
